Geneos Wealth Management’s iShares iBonds Dec 2021 Term Corporate ETF IBDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-7,271
| Closed | -$179K | – | 2941 |
|
|
2021
Q3 | $179K | Buy |
7,271
+1,704
| +31% | +$42.2K | 0.01% | 909 |
|
|
2021
Q2 | $137K | Sell |
5,567
-2,630
| -32% | -$65.2K | 0.01% | 1028 |
|
|
2021
Q1 | $203K | Buy |
8,197
+5
| +0.1% | +$124 | 0.01% | 960 |
|
|
2020
Q4 | $137K | Buy |
8,192
+2,678
| +49% | +$66.9K | 0.01% | 999 |
|
|
2020
Q3 | $138K | Sell |
5,514
-523
| -9% | -$13.1K | 0.01% | 815 |
|
|
2020
Q2 | $151K | Buy |
6,037
+25
| +0.4% | +$625 | 0.01% | 753 |
|
|
2020
Q1 | $147K | Buy |
6,012
+4,017
| +201% | +$99.6K | 0.01% | 716 |
|
|
2019
Q4 | $49K | Hold |
1,995
| – | – | ﹤0.01% | 1277 |
|
|
2019
Q3 | $49K | Sell |
1,995
-1,585
| -44% | -$39.5K | ﹤0.01% | 1199 |
|
|
2019
Q2 | $89K | Buy |
3,580
+45
| +1% | +$1.11K | 0.01% | 950 |
|
|
2019
Q1 | $87K | Buy |
3,535
+1,835
| +108% | +$45K | 0.01% | 917 |
|
|
2018
Q4 | $41K | Hold |
1,700
| – | – | ﹤0.01% | 1199 |
|
|
2018
Q3 | $41K | Buy |
1,700
+1,200
| +240% | +$29.2K | ﹤0.01% | 1269 |
|
|
2018
Q2 | $12K | Sell |
500
-1,200
| -71% | -$29.2K | ﹤0.01% | 1664 |
|
|
2018
Q1 | $41K | Sell |
1,700
-600
| -26% | -$14.7K | ﹤0.01% | 1091 |
|
|
2017
Q4 | $57K | Hold |
2,300
| – | – | 0.01% | 948 |
|
|
2017
Q3 | $57K | Buy |
2,300
+600
| +35% | +$15K | 0.01% | 893 |
|
|
2017
Q2 | $42K | Buy |
+1,700
| New | +$42.4K | ﹤0.01% | 1003 |
|
Other funds holding IBDM
Geneos Wealth Management's IBDM Position: Q4 2021 in Review
Geneos Wealth Management sold out of iShares iBonds Dec 2021 Term Corporate ETF (IBDM) in Q4 2021, closing a stake of 7,271 shares — an estimated $179K sold.
Geneos Wealth Management first reported a position in IBDM in Q2 2017 and held it in 18 quarters. The position peaked at $203K in Q1 2021. 1 fund tracked by Wall St. Rank holds IBDM as of Q4 2021.
- Geneos Wealth Management reported no remaining iShares iBonds Dec 2021 Term Corporate ETF position as of Q4 2021 after selling out during the quarter.
- Geneos Wealth Management sold 7,271 iShares iBonds Dec 2021 Term Corporate ETF shares in Q4 2021, an estimated $179K.
- Geneos Wealth Management first reported a position in iShares iBonds Dec 2021 Term Corporate ETF in Q2 2017 and held it in 18 quarters.
- Geneos Wealth Management's iShares iBonds Dec 2021 Term Corporate ETF position peaked at $203K in Q1 2021.
- 1 fund tracked by Wall St. Rank held iShares iBonds Dec 2021 Term Corporate ETF as of Q4 2021.
Based on Geneos Wealth Management's 13F filing for Q4 2021, filed 9 Feb 2022.